Immune to Cancer: The CRI Blog
-
Join #TeamCRI and Plan Your Own Tailgate for a Purpose
The Cancer Research Institute (CRI) now has a new way to create a world immune to cancer,… -
CRI’s Dr. Jill O’Donnell-Tormey Explains Five Things You Need to Know About Cancer Vaccines
Vaccines had been effective at preventing viral and bacterial-borne viruses for two hundred years before the first… -
Recent Innovations and Challenges in Fighting Blood Cancers
The term “blood cancer” encompasses several types of cancer, including leukemia, lymphoma, multiple myeloma, myelodysplastic syndromes (MDS),… -
A CRI Board Member’s Father was Diagnosed with Cancer – He Quickly Raised Over $150,000 for Research
It started with an idea. Yacov Arnopolin wanted to raise money for a cause that was close… -
Dr. Jill O’Donnell-Tormey Discusses the Latest Developments in Immunological Technologies
CRI’s CEO and Director of Scientific Affairs, Dr. Jill O’Donnell-Tormey, recently spoke with ecancer about recent developments… -
Sarcomas: Unique Cancers that Merit Further Attention and Research
Sarcomas are unique compared to other types of cancer variations. In contrast to carcinomas, which arise from… -
Why Do We Get Cancer? How Our Lifestyles Impact Our Risk
There are many factors that dictate whether someone will develop cancer, and they fall roughly into two… -
Rising Female Talents in Cancer Immunotherapy Research
In recent years, there has been a renewed and welcomed focus on female scientists in STEM (science,…

Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.